The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs
ST Diepstraten, MA Anderson, PE Czabotar… - Nature Reviews …, 2022 - nature.com
Apoptosis is a form of programmed cell death that is regulated by the balance between
prosurvival and proapoptotic BCL-2 protein family members. Evasion of apoptosis is a …
prosurvival and proapoptotic BCL-2 protein family members. Evasion of apoptosis is a …
MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents
A Bolomsky, M Vogler, MC Köse, CA Heckman… - Journal of hematology & …, 2020 - Springer
Cell death escape is one of the most prominent features of tumor cells and closely linked to
the dysregulation of members of the Bcl-2 family of proteins. Among those, the anti-apoptotic …
the dysregulation of members of the Bcl-2 family of proteins. Among those, the anti-apoptotic …
ERK1/2 in immune signalling
Extracellular signal-related kinases 1 and 2 (ERK1/2) are the final components of the
mitogen-activated protein kinase (MAPK) phosphorylation cascade, an integral module in a …
mitogen-activated protein kinase (MAPK) phosphorylation cascade, an integral module in a …
BRAF—A tumour-agnostic drug target with lineage-specific dependencies
In June 2022, the FDA granted Accelerated Approval to the BRAF inhibitor dabrafenib in
combination with the MEK inhibitor trametinib for the treatment of adult and paediatric …
combination with the MEK inhibitor trametinib for the treatment of adult and paediatric …
Mechanisms of acquired BRAF inhibitor resistance in melanoma: a systematic review
I Proietti, N Skroza, N Bernardini, E Tolino, V Balduzzi… - Cancers, 2020 - mdpi.com
Simple Summary Patients with advanced melanoma are often treated with v-raf murine
sarcoma viral oncogene homolog B1 (BRAF) inhibitors. Although these agents prolong life …
sarcoma viral oncogene homolog B1 (BRAF) inhibitors. Although these agents prolong life …
Understanding drug sensitivity and tackling resistance in cancer
Decades of research into the molecular mechanisms of cancer and the development of
novel therapeutics have yielded a number of remarkable successes. However, our ability to …
novel therapeutics have yielded a number of remarkable successes. However, our ability to …
Targeting MCL-1 protein to treat cancer: opportunities and challenges
SI Tantawy, N Timofeeva, A Sarkar, V Gandhi - Frontiers in oncology, 2023 - frontiersin.org
Evading apoptosis has been linked to tumor development and chemoresistance. One
mechanism for this evasion is the overexpression of prosurvival B-cell lymphoma-2 (BCL-2) …
mechanism for this evasion is the overexpression of prosurvival B-cell lymphoma-2 (BCL-2) …
Bioactive NIR‐II Light‐Responsive shape memory composite based on cuprorivaite nanosheets for endometrial regeneration
Intrauterine adhesions (IUAs) caused by mechanical damage or infection increase the risk of
infertility in women. Although numerous physical barriers such as balloon or hydrogel are …
infertility in women. Although numerous physical barriers such as balloon or hydrogel are …
Discovery of a Myeloid Cell Leukemia 1 (Mcl-1) Inhibitor That Demonstrates Potent In Vivo Activities in Mouse Models of Hematological and Solid Tumors
JC Tarr, JM Salovich, M Aichinger… - Journal of Medicinal …, 2024 - ACS Publications
Myeloid cell leukemia 1 (Mcl-1) is a key regulator of the intrinsic apoptosis pathway.
Overexpression of Mcl-1 is correlated with high tumor grade, poor survival, and both intrinsic …
Overexpression of Mcl-1 is correlated with high tumor grade, poor survival, and both intrinsic …
Executioner caspases restrict mitochondrial RNA-driven Type I IFN induction during chemotherapy-induced apoptosis
During apoptosis, mitochondrial outer membrane permeabilization (MOMP) enables certain
mitochondrial matrix macromolecules to escape into the cytosol. However, the fate of …
mitochondrial matrix macromolecules to escape into the cytosol. However, the fate of …